Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439226![]() (US10604514, Compound 103) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 30 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439230![]() (US10604514, Compound 108) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 671 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439236![]() (US10604514, Compound 126) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 24 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439244![]() (US10604514, Compound 137) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 68 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439254![]() (US10604514, Compound 149) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 128 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439265![]() (US10604514, Compound 161 | US10604514, Compound 16...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 4.27E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439280![]() (US10604514, Compound 194) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439286![]() (US10604514, Compound 224 | US10604514, Compound 22...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 703 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439291![]() (US10604514, Compound 229) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 6.71E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439137![]() (US10604514, Compound 13 | US10604514, Compound 143) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439140![]() (US10604514, Compound 16) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439143![]() (US10604514, Compound 19) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 110 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439156![]() (US10604514, Compound 32) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439157![]() (US10604514, Compound 33) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439159![]() (US10604514, Compound 139 | US10604514, Compound 35) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439178![]() (US10604514, Compound 54) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439182![]() (US10604514, Compound 58) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439194![]() (US10604514, Compound 70) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM293657![]() (US10106527, Compound 464 | US10544128, Compound 46...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM293561![]() (US10106527, Compound 268 | US10544128, Compound 26...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439230![]() (US10604514, Compound 108) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM385372![]() (US10287267, Compound 1082 | US10508099, Compound 1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM385167![]() (US10287267, Compound 327 | US10508099, Compound 10...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439252![]() (US10604514, Compound 147) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 18 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439126![]() (US10604514, Compound 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 246 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM293463![]() (US10106527, Compound 67 | US10544128, Compound 67 ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.58E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439135![]() (US10604514, Compound 11) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439136![]() (US10604514, Compound 12) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 189 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439144![]() (US10604514, Compound 20) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 41 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439158![]() (US10604514, Compound 34) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 46 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM385177![]() (US10287267, Compound 338 | US10508099, Compound 33...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 96 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439173![]() (US10604514, Compound 49) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439179![]() (US10604514, Compound 55) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 88 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439183![]() (US10604514, Compound 59) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM385177![]() (US10287267, Compound 338 | US10508099, Compound 33...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 66 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439208![]() (US10604514, Compound 84 | US10604514, Compound 85 ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.74E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439225![]() (US10604514, Compound 102) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 434 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439238![]() (US10604514, Compound 129) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 90 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439252![]() (US10604514, Compound 147) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 37 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439260![]() (US10604514, Compound 156) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 34 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439261![]() (US10604514, Compound 157) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439273![]() (US10604514, Compound 168) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439275![]() (US10604514, Compound 170) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 52 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439282![]() (US10604514, Compound 196) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 194 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Axin-1/Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM439286![]() (US10604514, Compound 224 | US10604514, Compound 22...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant GSK3β kinase, ATP and Ser/Thr peptide 09 are prepared in 1× Kinase buffer to final concentrations of 0.04 μg/mL, 46 &... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439128![]() (US10604514, Compound 4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM385079![]() (US10287267, Compound 1086 | US10287267, Compound 1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439136![]() (US10604514, Compound 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439147![]() (US10604514, Compound 23) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (Homo sapiens (Human)) | BDBM439150![]() (US10604514, Compound 26) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 38 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Briefly, recombinant DYRK1A kinase, ATP and Ser/Thr peptide 18 were prepared in 1× Kinase buffer to final concentrations of 0.19 μg/mL, 30 _... | US Patent US10604514 (2020) | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 334 total ) | Next | Last >> |